During the forecast period, the market for geriatric medications is anticipated to expand significantly. The expansion of this market can be attributed to emerging markets and significant investments in R&D. The growth of geriatric medicines market is enhanced by the growing cases of orthopedics diseases such as osteoporosis and arthritis, the vulnerable aging population and the rise in research and development activities conducted by many pharmaceutical companies. COVID-19 also had a major impact on the market growth.
